Microsoft Word - RadBio_Programme_ParisSept2017

Small molecule EGFR inhibitors

ZD1839

Ligand

• orally bioavailable

• selective inhibitor of EGFR

tyrosine kinase

• competitive inhibitor of ATP-

binding

IRESSA / ZD1839



Proliferation, DNA repair, angiogenesis

No downstream signalling

  